FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3003877091> ?p ?o ?g. }

• W3003877091 endingPage "e0228207" @default.
• W3003877091 startingPage "e0228207" @default.
• W3003877091 abstract "Primaquine is an approved radical cure treatment for Plasmodium vivax malaria but treatment can result in life-threatening hemolysis if given to a glucose-6-phosphate dehydrogenase deficient (G6PDd) patient. There is a need for reliable point-of-care G6PD diagnostic tests.To evaluate the performance of the CareStart™ rapid diagnostic test (RDT) in the hands of healthcare workers (HCWs) and village malaria workers (VMWs) in field settings, and to better understand user perceptions about the risks and benefits of PQ treatment guided by RDT results.This study enrolled 105 HCWs and VMWs, herein referred to as trainees, who tested 1,543 healthy adult male volunteers from 84 villages in Cambodia. The trainees were instructed on G6PD screening, primaquine case management, and completed pre and post-training questionnaires. Each trainee tested up to 16 volunteers in the field under observation by the study staff.Out of 1,542 evaluable G6PD volunteers, 251 (16.28%) had quantitative enzymatic activity less than 30% of an adjusted male median (8.30 U/g Hb). There was no significant difference in test sensitivity in detecting G6PDd between trainees (97.21%), expert study staff in the field (98.01%), and in a laboratory setting (95.62%) (p = 0.229); however, test specificity was different for trainees (96.62%), expert study staff in the field (98.14%), and experts in the laboratory (98.99%) (p < 0.001). Negative predictive values were not statistically different for trainees, expert staff, and laboratory testing: 99.44%, 99.61%, and 99.15%, respectively. Knowledge scores increased significantly post-training, with 98.7% willing to prescribe primaquine for P.vivax malaria, an improvement from 40.6% pre-training (p < 0.001).This study demonstrated ability of medical staff with different background to accurately use CareStart™ RDT to identify G6PDd in male patients, which may enable safer prescribing of primaquine; however, pharmacovigilance is required to address possible G6PDd misclassifications." @default.
• W3003877091 created "2020-02-07" @default.
• W3003877091 creator A5001379375 @default.
• W3003877091 creator A5001655402 @default.
• W3003877091 creator A5004390572 @default.
• W3003877091 creator A5004994335 @default.
• W3003877091 creator A5006306416 @default.
• W3003877091 creator A5007882199 @default.
• W3003877091 creator A5013688884 @default.
• W3003877091 creator A5029378779 @default.
• W3003877091 creator A5029555730 @default.
• W3003877091 creator A5032966568 @default.
• W3003877091 creator A5041986910 @default.
• W3003877091 creator A5045210044 @default.
• W3003877091 creator A5045291513 @default.
• W3003877091 creator A5046902147 @default.
• W3003877091 creator A5049209130 @default.
• W3003877091 creator A5050066617 @default.
• W3003877091 creator A5050474167 @default.
• W3003877091 creator A5060287758 @default.
• W3003877091 creator A5063685504 @default.
• W3003877091 creator A5066994436 @default.
• W3003877091 creator A5070777345 @default.
• W3003877091 creator A5073565761 @default.
• W3003877091 creator A5075351189 @default.
• W3003877091 creator A5077459663 @default.
• W3003877091 creator A5080741366 @default.
• W3003877091 creator A5081943097 @default.
• W3003877091 creator A5086466760 @default.
• W3003877091 creator A5086769089 @default.
• W3003877091 date "2020-01-31" @default.
• W3003877091 modified "2023-10-06" @default.
• W3003877091 title "Evaluation of the CareStart™ glucose-6-phosphate dehydrogenase (G6PD) rapid diagnostic test in the field settings and assessment of perceived risk from primaquine at the community level in Cambodia" @default.
• W3003877091 cites W2038084338 @default.
• W3003877091 cites W2116590229 @default.
• W3003877091 cites W2140498466 @default.
• W3003877091 cites W2158266463 @default.
• W3003877091 cites W2286108175 @default.
• W3003877091 cites W2329953645 @default.
• W3003877091 cites W2495040394 @default.
• W3003877091 cites W2531728433 @default.
• W3003877091 cites W2586377766 @default.
• W3003877091 cites W2623207549 @default.
• W3003877091 cites W2756281098 @default.
• W3003877091 cites W2809041220 @default.
• W3003877091 doi "https://doi.org/10.1371/journal.pone.0228207" @default.
• W3003877091 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6994100" @default.
• W3003877091 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32004348" @default.
• W3003877091 hasPublicationYear "2020" @default.
• W3003877091 type Work @default.
• W3003877091 sameAs 3003877091 @default.
• W3003877091 citedByCount "6" @default.
• W3003877091 countsByYear W30038770912021 @default.
• W3003877091 countsByYear W30038770912022 @default.
• W3003877091 countsByYear W30038770912023 @default.
• W3003877091 crossrefType "journal-article" @default.
• W3003877091 hasAuthorship W3003877091A5001379375 @default.
• W3003877091 hasAuthorship W3003877091A5001655402 @default.
• W3003877091 hasAuthorship W3003877091A5004390572 @default.
• W3003877091 hasAuthorship W3003877091A5004994335 @default.
• W3003877091 hasAuthorship W3003877091A5006306416 @default.
• W3003877091 hasAuthorship W3003877091A5007882199 @default.
• W3003877091 hasAuthorship W3003877091A5013688884 @default.
• W3003877091 hasAuthorship W3003877091A5029378779 @default.
• W3003877091 hasAuthorship W3003877091A5029555730 @default.
• W3003877091 hasAuthorship W3003877091A5032966568 @default.
• W3003877091 hasAuthorship W3003877091A5041986910 @default.
• W3003877091 hasAuthorship W3003877091A5045210044 @default.
• W3003877091 hasAuthorship W3003877091A5045291513 @default.
• W3003877091 hasAuthorship W3003877091A5046902147 @default.
• W3003877091 hasAuthorship W3003877091A5049209130 @default.
• W3003877091 hasAuthorship W3003877091A5050066617 @default.
• W3003877091 hasAuthorship W3003877091A5050474167 @default.
• W3003877091 hasAuthorship W3003877091A5060287758 @default.
• W3003877091 hasAuthorship W3003877091A5063685504 @default.
• W3003877091 hasAuthorship W3003877091A5066994436 @default.
• W3003877091 hasAuthorship W3003877091A5070777345 @default.
• W3003877091 hasAuthorship W3003877091A5073565761 @default.
• W3003877091 hasAuthorship W3003877091A5075351189 @default.
• W3003877091 hasAuthorship W3003877091A5077459663 @default.
• W3003877091 hasAuthorship W3003877091A5080741366 @default.
• W3003877091 hasAuthorship W3003877091A5081943097 @default.
• W3003877091 hasAuthorship W3003877091A5086466760 @default.
• W3003877091 hasAuthorship W3003877091A5086769089 @default.
• W3003877091 hasBestOaLocation W30038770911 @default.
• W3003877091 hasConcept C126322002 @default.
• W3003877091 hasConcept C151730666 @default.
• W3003877091 hasConcept C160735492 @default.
• W3003877091 hasConcept C162324750 @default.
• W3003877091 hasConcept C203014093 @default.
• W3003877091 hasConcept C2776793103 @default.
• W3003877091 hasConcept C2777267654 @default.
• W3003877091 hasConcept C2777425658 @default.
• W3003877091 hasConcept C2778048844 @default.
• W3003877091 hasConcept C2778119762 @default.
• W3003877091 hasConcept C2778371730 @default.
• W3003877091 hasConcept C2779997623 @default.
• W3003877091 hasConcept C2909011893 @default.

• next